Explore the words cloud of the PREMUROSA project. It provides you a very rough idea of what is the project "PREMUROSA" about.
The following table provides information about the project.
Coordinator |
UNIVERSITA DEGLI STUDI DEL PIEMONTE ORIENTALE AMEDEO AVOGADRO
Organization address contact info |
Coordinator Country | Italy [IT] |
Total cost | 3˙348˙405 € |
EC max contribution | 3˙348˙405 € (100%) |
Programme |
1. H2020-EU.1.3.1. (Fostering new skills by means of excellent initial training of researchers) |
Code Call | H2020-MSCA-ITN-2019 |
Funding Scheme | MSCA-ITN-ETN |
Starting year | 2020 |
Duration (year-month-day) | from 2020-01-01 to 2023-12-31 |
Take a look of project's partnership.
# | ||||
---|---|---|---|---|
1 | UNIVERSITA DEGLI STUDI DEL PIEMONTE ORIENTALE AMEDEO AVOGADRO | IT (VERCELLI) | coordinator | 522˙999.00 |
2 | INEB-INSTITUTO NACIONAL DE ENGENHARIA BIOMEDICA | PT (PORTO) | participant | 475˙440.00 |
3 | AO-FORSCHUNGSINSTITUT DAVOS | CH (DAVOS PLATZ) | participant | 281˙276.00 |
4 | AALTO KORKEAKOULUSAATIO SR | FI (ESPOO) | participant | 280˙805.00 |
5 | TAMPEREEN KORKEAKOULUSAATIO SR | FI (TAMPERE) | participant | 280˙805.00 |
6 | NATIONAL UNIVERSITY OF IRELAND GALWAY | IE (Galway) | participant | 274˙684.00 |
7 | ENGINSOFT SPA | IT (TRENTO) | participant | 261˙499.00 |
8 | ISTITUTO ORTOPEDICO RIZZOLI | IT (BOLOGNA) | participant | 261˙499.00 |
9 | POLITECNICO DI TORINO | IT (TORINO) | participant | 261˙499.00 |
10 | RIGAS TEHNISKA UNIVERSITATE | LV (RIGA) | participant | 230˙068.00 |
11 | FACULTY OF TECHNOLOGY AND METALLURGY UNIVERSITY OF BELGRADE | RS (BELGRADE) | participant | 217˙825.00 |
Muscoloskeletal diseases are a major burden on individuals, healthcare and welfare systems. Treatment of muscolo-skeletal disorders is currently based either on prosthetic or regenerative surgical procedures, often involving medical device implantation. In both cases, individual tissue healing and regeneration, together with the appropriateness of the implanted device, markedly affect the outcome. A great improvement could be achieved by precision medicine, specifically designed on patient’s individual characteristics. This implies to combine the personalized clinical approach with individual ‘omic’ characterization and proper choice of medical device. The concept is “To take care with care”. This is the meaning of the Italian word “premurosa” and the ultimate goal of the ITN PREMUROSA project, aimed to train a new generation of scientists with an integrated vision of the whole value chain in muscolo-skeletal regeneration technologies and able to boost the necessary innovations to achieve precision principles in developing innovative devices and optimized clinical applications. This aim will be achieved by a “triple i” (interdisciplinary, intersectoral, international) approach of thirteen ESRs, who will benefit from an excellent scientific environment, up-date technologies and supervision by international leaders in the field. They will learn to integrate academic and industrial aspects and they will sharpen their experimental and complementary skills in a well-designed and diversified and unprecedented training program.
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "PREMUROSA" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "PREMUROSA" are provided by the European Opendata Portal: CORDIS opendata.
Interactive Natural Language Technology for Explainable Artificial Intelligence
Read MoreSupporting the interaction of Humans and Automated vehicles: Preparing for the EnvIronment of Tomorrow
Read MoreSuperCol: Rational design of super-selective and responsive colloidal particles for biomedical applications
Read More